Topics
Medical news by topic
Every item from our daily digests, grouped by company and theme.
Approvals & regulatory
FDA, EMA and other regulator approvals, rejections, filings, guidance and programs.
12 items
Drug & device safety
Safety communications, recalls, trial deaths, adverse events and pharmacovigilance.
7 items
Oncology
Cancer drugs, trials, vaccines and approvals.
4 items
Infectious disease
Outbreaks, vaccines, antivirals and global health.
4 items
Neurology
Multiple sclerosis, Alzheimer's, stroke and neuroscience drug development.
2 items
Obesity & metabolic
GLP-1s, diabetes, obesity and cardiometabolic medicine.
2 items
Immunology & autoimmune
Autoimmune disease, immunology drugs and cell therapy outside cancer.
2 items
Journal papers
Major trials and papers in NEJM, The Lancet, JAMA and BMJ.
1 item
Pharma industry
Deals, earnings, launches and strategy across pharma and biotech.
3 items
Markets
Pharma, biotech and medtech stock-moving news: earnings, FDA-decision moves, M&A, IPOs and big trial readouts. Figures are quoted from sources only. Not investment advice.
4 items
Nutraceuticals & supplements
Dietary supplements, functional nutrition, ingredient science, and supplement regulation (FDA DSHEA, FSSAI, EFSA).
2 items
Cosmetics & skincare
Skincare, sunscreen, beauty industry and cosmetics regulation (MoCRA, EU SCCS, CDSCO).
2 items
Consumer health & OTC
Over-the-counter medicines, consumer health companies and self-care products.
2 items
Daily email: coming soon
The day's approvals, safety signals and trials, in five minutes.
An email edition is on the way. Until then, bookmark this page or follow the RSS feed, a new digest is published every day.
Join the email waitlistOpens your email app. We only use your address to tell you when the email edition launches.
